StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.80−0.05 (-5.55%)

Close on Nov 19, 2026Market cap $51.51MP/E –Yield –

iBio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

iBio's shares outstanding was 152M at Sep 30, 2026. For fiscal 2026 it was 104M, up 891.1% from the year before. Over ten years it grew 140.3% a year on average. The highest annual figure on record is 104M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 2026104M+891.1%
FY2025Jun 30, 202510M+174.1%
FY2024Jun 30, 20244M+526.0%
FY2023Jun 30, 20231M+40.4%
FY2022Jun 30, 20220M+11.5%
FY2021Jun 30, 20210M+211.5%
FY2020Jun 30, 20200M+231.8%
FY2019Jun 30, 20190M+78.0%
FY2018Jun 30, 20180M+19.3%
FY2017Jun 30, 20170M+10.0%
FY2016Jun 30, 20160M+13.3%
FY2015Jun 30, 20150M+13.5%
FY2014Jun 30, 20140M+27.5%
FY2013Jun 30, 20130M+123350.0%
FY2012Jun 30, 20120M-99.9%
FY2011Jun 30, 20110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026152M+186.1%
Q4 FY2026CQ2 2026Jun 30, 2026145M+910.1%
Q3 FY2026CQ1 2026Mar 31, 2026120M+1112.7%
Q2 FY2026CQ4 2025Dec 31, 202599M+985.6%
Q1 FY2026CQ3 2025Sep 30, 202553M+513.7%
Q4 FY2025CQ2 2025Jun 30, 202514M+287.6%
Q3 FY2025CQ1 2025Mar 31, 202510M+431.4%
Q2 FY2025CQ4 2024Dec 31, 20249M+662.3%
Q1 FY2025CQ3 2024Sep 30, 20249M+906.2%
Q3 FY2024CQ1 2024Mar 31, 20244M+463.4%
Q2 FY2024CQ4 2023Dec 31, 20232M+278.8%
Q1 FY2024CQ3 2023Sep 30, 20231M+171.0%
Q4 FY2023CQ2 2023Jun 30, 20231M+96.6%
Q3 FY2023CQ1 2023Mar 31, 20231M+51.2%
Q2 FY2023CQ4 2022Dec 31, 20220M+12.9%
Q1 FY2023CQ3 2022Sep 30, 20220M+2.6%
Q4 FY2022CQ2 2022Jun 30, 20220M+16.0%
Q3 FY2022CQ1 2022Mar 31, 20220M+34.2%
Q4 FY2021CQ2 2021Jun 30, 20210M+97.1%
Q3 FY2021CQ1 2021Mar 31, 20210M+269323.8%
Q2 FY2021CQ4 2020Dec 31, 20200M+508243.2%
Q1 FY2021CQ3 2020Sep 30, 20200M+738272.7%
Q4 FY2020CQ2 2020Jun 30, 20200M+453.0%
Q3 FY2020CQ1 2020Mar 31, 20200M+321.1%
Q2 FY2020CQ4 2019Dec 31, 20190M+100.0%
Q1 FY2020CQ3 2019Sep 30, 20190M+22.2%
Q4 FY2019CQ2 2019Jun 30, 20190M+69.0%
Q3 FY2019CQ1 2019Mar 31, 20190M-99.8%
Q2 FY2019CQ4 2018Dec 31, 20180M-99.8%
Q1 FY2019CQ3 2018Sep 30, 20180M-99.8%
Q4 FY2018CQ2 2018Jun 30, 20180M+32.2%
Q3 FY2018CQ1 2018Mar 31, 20180M+29.6%
Q2 FY2018CQ4 2017Dec 31, 20170M+8.4%
Q1 FY2018CQ3 2017Sep 30, 20170M+3.1%
Q4 FY2017CQ2 2017Jun 30, 20170M–
Q3 FY2017CQ1 2017Mar 31, 20170M–
Q2 FY2017CQ4 2016Dec 31, 20160M–
Q1 FY2017CQ3 2016Sep 30, 20160M–

More iBio figures

See a number that looks wrong?